WikiJournalClub:Rubric
Clinical Question
Craft the clinical question being asked by the study in PICO (population, intervention, comparison, outcome) format.
Bottom Line
One or two sentences summarizing the purpose of the study and its outcomes.
Major Points
A few paragraphs summarizing the clinical question, the study itself, and how to apply it to practice. A simple approach is to use the first paragraph to discuss the background, use the second paragraph to discuss the study design and outcomes, and the third paragraph for interpretation which should incorporate criticisms, meta-analyses, and review-type content.
Guidelines
The relevant guidelines relating to this study, or {{no guidelines}}
if no guidelines are available.
Design
Bulleted list incorporating the following:
- Trial type (randomized, multicenter, etc.)
- N=number of patients randomized (often different from number of patients enrolled)
- Experimental arm (n=number of patients in this arm)
- Standard (n=number of patients in this arm)
- Setting: where the study took place (e.g., 25 centers in the US)
- Enrollment: years in which patients were enrolled (e.g., 2002-2008)
- Mean follow-up: years, months, etc. (e.g., 3.5 years)
- Analysis: main analysis type (e.g., intention-to-treat, per-protocol)
- Primary outcome: name the primary outcome (e.g., 3-year progression-free survival) Please do not list secondary or other outcomes.
Population
Inclusion Criteria
Bulleted list of the study's inclusion criteria.
Exclusion Criteria
Bulleted list of the study's exclusion criteria.
Baseline Characteristics
Bulleted list of baseline characteristics of the study population. Point out between-group differences that are clinically relevant. Pick only one of the groups to summarize. For RCTs, please omit P-values if presented by the journal.
Interventions
Description of the interventions employed in the trial, with enough supportive information to allow a non-expert MD to understand how patients were treated.
Outcomes
Primary Outcome
Description of the study's primary outcome, with statistical analysis including HR, RR, OR (when appropriate), 95% confidence intervals, and P values.
Secondary Outcomes
Same as above, for secondary outcomes.
Subgroup Analysis
Description of clinically relevant subgroup analyses for the primary outcome. Since these are usually underpowered (and occasionally post-hoc), they are thought of as only hypothesis-generating. If there wasn't any difference in any subgroup, no need to list out all of the statistics, can just write a sentence describing how the primary outcome was similar by prespecified subgroups, and list out the subgroups that were compared. If there were also post-hoc subgroup analyses (i.e., not prespecified), please indicate which subgroup analyses were post-hoc.
Adverse Events
Description of adverse events encountered in the study. Ensure that the most clinically relevant ones are here (e.g., bleeding in anticoagulant trials).
Criticisms
Bulleted list of internal (listed by the authors at the end of the discussion) and external criticisms (e.g., letters to the editor or editorial), with references for the external criticisms. Each criticism should be in a complete sentence to provide clarity. If the study did not meet its target enrollment, please include as a criticism.
Funding
One or two sentences about how the trial was funded.
Further Reading
This should usually just contain a single <references />
piece of markup which will list all citations references in the main text of the article entry.